The role of cytokines in cardiovascular disease in menopause

References

• Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90–119
   PubMed Web of Science ®Google Scholar
• Te Boekhorst BC, van Tilborg GA, Strijkers GJ, . Molecular MRI of inflammation in atherosclerosis. Curr Cardiovasc Imaging Rep 2012;5:60–8
   PubMedGoogle Scholar
• Kleeman R, Zadelaar S Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008;79:360–76
   PubMed Web of Science ®Google Scholar
• Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse. Arterioscler Thromb Vasc Biol 2006;26: 2421–32
   PubMed Web of Science ®Google Scholar
• Yu X, Dluz S, Graves DT, . Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 1992;89:6953–7
   PubMed Web of Science ®Google Scholar
• Schieffer B, Selle T, Hilfiker A, . Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 2004;110:3493–500
   PubMed Web of Science ®Google Scholar
• Lee YW, Kuhn H, Hennig B, . IL-4 induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J Mol Cell Cardiol 2001;33:83–94
   PubMed Web of Science ®Google Scholar
• Pacifici R, Rifas L, McCracken R. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 1989;86:2398–402
   PubMed Web of Science ®Google Scholar
• Pacifici R, Brown C, Puscheck E, . Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991;88: 5134–8
   PubMed Web of Science ®Google Scholar
• O’Brien CA, Gubrij I, Roberson PK, Jilka RL, Manolagas SC. In vivo demonstration of the negative transcriptional control of IL-6 gene by estrogen using IL-6 promoter luciferase transgenic mice. J Bone Miner Res 1999;14(Suppl 1):S179
   Google Scholar
• Lin SC, Yamate T, Taguchi Y, . Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J Clin Invest 1997;100:1980–90
   PubMed Web of Science ®Google Scholar
• Perry CD, Alekel DL, Ritland LM, . Centrally located body fat is related to inflammatory markers in healthy postmenopausal women. Menopause 2008;15:619–27
   PubMed Web of Science ®Google Scholar
• Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentration in normal-weight and obese women. Eur J Endocrinol 2002;147:173–80
   PubMed Web of Science ®Google Scholar
• Katsuki A, Sumida Y, Murashima S, . Serum levels of tumor necrosis factor alpha are increased in obese patients with noninsulin dependent diabetes mellitus. J Clin Endocrinol Metab 1998;83:859–62
   PubMed Web of Science ®Google Scholar
• Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissue of obese subjects release interleukin 6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998;83:847–50
   PubMed Web of Science ®Google Scholar
• Di Renzo L, Bigioni M, Del Gobbo V, . Interleukin-1 receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels. Pharmacol Res 2007;5:131–8
   Web of Science ®Google Scholar
• Yudkin JS, Stehouwer CD, Emeiss JJ, Coppack SW. C Reactive protein in healthy subjects: association with obesity, insulin resistance and endothelial dysfunctions: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999;19:972–8
   PubMed Web of Science ®Google Scholar
• Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327–32
   PubMed Web of Science ®Google Scholar
• Straub RH, Hense HW, Andus T, Scholmerich J, Riegger GA, Schunkert H. Hormone replacement therapy and interrelation between serum interleukin 6 and body mass index in postmenopausal women: a population based study. J Clin Endocrinol Metab 2000;85:1340–4
   PubMed Web of Science ®Google Scholar
• Zhao Y, Nichols JE, Bulun SE, Mendelson CR, Simson ER. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem 1995;270:16449–57
   PubMed Web of Science ®Google Scholar
• Wong E, Freiberg M, Tracy R, . Epidemiology of cytokines. The Women on the Move through Activity and Nutrition (WOMAN) study. Am J Epidemiol 2008;168:443–53
   PubMed Web of Science ®Google Scholar
• Sowers MR, Wildman RP, Mancuso P, . Changes in adipocytokines and ghrelin with menopause. Maturitas 2008;59: 149–57
   PubMed Web of Science ®Google Scholar
• Meier U, Gressner AM. Endrocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 2004;50: 1511–25
   PubMed Web of Science ®Google Scholar
• Dafopoulos K, Chalvatzas N, Kosmas G, . The effect of estrogens on plasma ghrelin concentrations in women. J Endocrinol Invest2010;33:109–12
   PubMed Web of Science ®Google Scholar
• Calermajer DS, Sorensen KE, Spiegelhalter DJ, . Aging is associated with endothelial dysfunction in healthy men years before the age related decline in women. J Am Coll Cardiol 1994;24:471–6
   PubMed Web of Science ®Google Scholar
• Arenas IA, Armstrong SJ, Xu Y, . Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen-deficient rats. Hypertension 2005;46:76–81
   PubMed Web of Science ®Google Scholar
• Arenas IA, Armstrong SJ, Xu Y, . Age associated impairment in vasorelaxation to fluid shear stress in the female vasculature is improved by TNF-α antagonism. Am J Physiol – Heart 2006;290:H1259–63
   Web of Science ®Google Scholar
• Arenas IA, Armstrong SJ, Xu Y, . Tumor necrosis factor-alpha and vascular angiotensin 2 in estrogen deficient rats. Hypertension 2006;48:497–503
   PubMed Web of Science ®Google Scholar
• Lekontseva O, Jiang Y, Davidge ST. Estrogen replacement increases matrix metalloproteinase contribution to vasoconstriction in a rat model of menopause. J Hypertension 2009; 27:1602–8
   PubMed Web of Science ®Google Scholar
• Lekonsteva ON, Rueda-Clausen CF, Morton JS, . Ovariectomy in aged versus young rats augments matrix metalloproteinase-mediated vasoconstriction in mesenteric arteries. Menopause 2010;17:516–23
   PubMed Web of Science ®Google Scholar
• Liu S, Tinker L, Song Y, . A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007;167:1976–85
   Google Scholar
• Rajpathak SN, Wassertheil-Smoller S, Crandall J, . Hepatocyte growth factor and clinical diabetes in postmenopausal women. Diabetes Care 2010;33:2013–15
   PubMed Web of Science ®Google Scholar
• Furuhashi M, Hotamisligil GS. Fatty acid binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 2008;7:489–503
   PubMed Web of Science ®Google Scholar
• Chan KK, Song Y, Hsu Y, . Common genetic variations in fatty acid-binding protein-4 (FABP4) and clinical diabetes risk in the Women's Health Initiative observational study. Obesity 2010;18:1812–20
   PubMed Web of Science ®Google Scholar
• Kaplan RC, McGinn AP, Baird AE, . Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative observational study. J Stroke Cerberovasc Dis 2008;17:344–55
   PubMedGoogle Scholar
• Wassetheil-Smoller S, Kooperberg C, McGinn AP, . Lipoprotein-associated phospholipase A2, hormone use and the risk of ischemic stroke in postmenopausal women. Hypertension 2008;51:1115–22
   PubMed Web of Science ®Google Scholar
• Moultan KS, Vakili K, Zurakowski D, . Inhibition of plaque neovascularisation reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003;100:4736–41
   PubMed Web of Science ®Google Scholar
• Saltiki K, Alevizaki M. Coronary heart disease in postmenopausal women; the role of endogenous estrogens and their receptors. Hormones 2007;6:9–24
   PubMedGoogle Scholar
• Mysliwska J, Rutkowska A, Hak L, . Inflammatory response of coronary artery disease postmenopausal women is associated with IVS1–397T > C estrogen receptor alpha polymorphism. Clin Immunol 2009;130:355–64
   PubMed Web of Science ®Google Scholar
• Herrington DM, Howard TD, Brosnihan KB, . Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E selectin but not C reactive protein. Circulation 2002;105:1879–82
   PubMed Web of Science ®Google Scholar
• Liu H, Liu K, Bodenner DL, . Estrogen receptor inhibits interleukin 6 gene expression by disruption of nuclear factor kappa B transactivation. Cytokine 2005;31:251–7
   PubMed Web of Science ®Google Scholar
• Sukovich DA, Kauser K, Shirley FD. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice. Arterioscl Thromb Vasc Biol 1998;18:1498–505
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Manson JE, Rossouw JE, . Inflammatory biomarkers, hormone replacement therapy and incident coronary heart disease. JAMA 2002;288:980–7
   PubMed Web of Science ®Google Scholar
• Silvestri A, Gebara O, Vitale C, . Increased levels of C reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation 2003;107:3165–9
   PubMed Web of Science ®Google Scholar
• Decensi A, Omodei U, Robertson C, . Effect of transdermal estradiol and oral conjugated estrogen on C reactive protein in retinoid–placebo trial in healthy women. Circulation 2002; 106:1224–8
   PubMed Web of Science ®Google Scholar
• Vitale C, Cornoldi A, Gebara O, . Interleukin-6 and flow mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. Menopause 2005;12:552–8
   PubMed Web of Science ®Google Scholar
• Ozatas E, Kurtay G. Effects of raloxifene on serum macrophage colony-stimulating factor and interleukin-18 levels in postmenopausal women younger than 60 years. Menopause 2010;17:1188–93
   PubMed Web of Science ®Google Scholar
• Saitta A, Morabito N, Frisina N, . Cardiovascular effects of raloxifene hydrochloride. Cardiovasc Drug Rev 2001;19:57–74
   PubMed Web of Science ®Google Scholar
• Malpuech-Brugère C, Nowacki W, Daveau M, . Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 2000;1501:91–8
   PubMed Web of Science ®Google Scholar
• Chacko SA, Song Y, Nathan L, . Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010;33:304–10
   PubMed Web of Science ®Google Scholar
• Salas-Salvado J, Casas-Agustench P, Murphy MM, . The effects of nuts on inflammation. Asia Pac J Clin Nutr 2008;17(Suppl 1):333–6
   PubMed Web of Science ®Google Scholar
• Nasca MM, Zhou JR, Weity FK. Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol 2008;102: 84–6
   PubMed Web of Science ®Google Scholar
• Tchernof A, Nolan A, Sites CK, . Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002;105:564–9
   PubMed Web of Science ®Google Scholar
• Bastard JP, Jardel C, Bruckert E, . Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338–42
   PubMed Web of Science ®Google Scholar
• Curtis PJ, Kroon PA, Hollands WJ. Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingestion of elderberry extract rich in anthocyanins for 12 weeks. J Nutr 2009;139:2266–71
   PubMed Web of Science ®Google Scholar
• Kelley DS, Rasooly R, Jacob RA, . Consumption of Bing sweet cherries lowers circulating concentrations of inflammatory markers in healthy men and women. J Nutr 2006;136:981–6
   PubMed Web of Science ®Google Scholar
• Karlsen A, Retterstol L, Laake P, . Anthocyanins inhibit nuclear factor-kappa B activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr 2007;137:1951–4
   PubMed Web of Science ®Google Scholar
• Mueller M, Hobiger S, Jungbauer A. Red clover extract: a source for substances that activate peroxisome proliferator-activated receptor alpha and ameliorate the cytokine secretion profile of lipopolysaccharide-stimulated macrophages. Menopause 2012;17:379–87
   Web of Science ®Google Scholar
• Terzic MM, Dotlic J, Maricic S, . Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women. J Obstet Gynaecol Res 2009;35:1091–5
   PubMed Web of Science ®Google Scholar
• Simoncini T, Garibaldi S, Fu XD, . Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause 2008;15:542–50
   PubMed Web of Science ®Google Scholar
• Arsenault BJ, Cote M, Cartier A, . Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese postmenopausal women with elevated blood pressure. Atherosclerosis 2009;207: 530–3
   PubMed Web of Science ®Google Scholar
• Prestes J, Shiguemoto G, Betero JP, . Effects of resistance training on resistin, leptin, cytokines and muscle force in elderly postmenopausal women. J Sports Sci 2009;27:1607–15
   PubMed Web of Science ®Google Scholar